Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Atara Biotherapeutics, Inc. (ATRA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2023 |
4
| Touchon Pascal (President and CEO) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Sold 14,291 shares
@ $1.66, valued at
$23.7k
|
|
| 06/02/2023 |
4
| SEIDENBERG BETH C (Director) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Granted 57,000 shares
@ $0
Granted 79,500 options to buy
@ $1.53, valued at
$121.6k
|
|
| 06/02/2023 |
4
| Roncarolo Maria Grazia (Director) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Granted 57,000 shares
@ $0
Granted 79,500 options to buy
@ $1.53, valued at
$121.6k
|
|
| 06/02/2023 |
4
| Gallagher Carol Giltner (Director) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Granted 57,000 shares
@ $0
Granted 79,500 options to buy
@ $1.53, valued at
$121.6k
|
|
| 06/02/2023 |
4
| Fust Matthew K (Director) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Granted 57,000 shares
@ $0
Granted 79,500 options to buy
@ $1.53, valued at
$121.6k
|
|
| 06/02/2023 |
4
| MALLIK AMEET (Director) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Granted 57,000 shares
@ $0
Granted 79,500 options to buy
@ $1.53, valued at
$121.6k
|
|
| 06/02/2023 |
4
| DOBMEIER ERIC (Director) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Granted 57,000 shares
@ $0
Granted 79,500 options to buy
@ $1.53, valued at
$121.6k
|
|
| 06/02/2023 |
4
| HEIDEN WILLIAM K (Director) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Granted 57,000 shares
@ $0
Granted 79,500 options to buy
@ $1.53, valued at
$121.6k
|
|
| 05/18/2023 |
4
| Murugan Amar (EVP, Chief Legal Officer) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Sold 7,404 shares
@ $2.037, valued at
$15.1k
Sold 985 shares
@ $2.038, valued at
$2k
|
|
| 05/18/2023 |
4
| Touchon Pascal (President and CEO) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Sold 29,766 shares
@ $2.037, valued at
$60.6k
|
|
| 05/18/2023 |
4
| Banard Charlene A. (EVP, Chief Technical Officer) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Sold 19,040 shares
@ $2.037, valued at
$38.8k
|
|
| 05/18/2023 |
4
| Hyllengren Eric J (SVP, CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Sold 6,199 shares
@ $2.037, valued at
$12.6k
Sold 1,719 shares
@ $2.038, valued at
$3.5k
|
|
| 03/06/2023 |
4
| Touchon Pascal (President and CEO) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Sold 15,679 shares
@ $3.627, valued at
$56.9k
|
|
| 03/06/2023 |
4
| Murugan Amar (SVP, GC & Secretary) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Sold 4,221 shares
@ $3.627, valued at
$15.3k
|
|
| 03/06/2023 |
4
| Koppikar Utpal (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Sold 6,871 shares
@ $3.627, valued at
$24.9k
|
|
| 03/06/2023 |
4
| Dupont Jakob (EVP, Head of R&D) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Sold 5,074 shares
@ $3.627, valued at
$18.4k
|
|
| 02/09/2023 |
4
| Koppikar Utpal (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Sold 2,485 shares
@ $5.46, valued at
$13.6k
|
|
| 11/18/2022 |
4
| Dupont Jakob (EVP, Head of R&D) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Sold 3,218 shares
@ $4.49, valued at
$14.4k
Sold 1,124 shares
@ $4.491, valued at
$5k
|
|
| 11/18/2022 |
4
| Touchon Pascal (President and CEO) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Sold 15,591 shares
@ $4.49, valued at
$70k
|
|
| 11/18/2022 |
4
| Murugan Amar (SVP, GC & Secretary) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Sold 3,612 shares
@ $4.49, valued at
$16.2k
|
|
| 11/18/2022 |
4
| Koppikar Utpal (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Sold 5,172 shares
@ $4.49, valued at
$23.2k
Sold 1,083 shares
@ $4.491, valued at
$4.9k
|
|
| 08/18/2022 |
4
| Touchon Pascal (President and CEO) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Sold 14,806 shares
@ $5.035, valued at
$74.5k
|
|
| 08/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2022 |
4
| Touchon Pascal (President and CEO) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Sold 14,220 shares
@ $7.2, valued at
$102.4k
|
|
| 06/27/2022 |
4
| Gallagher Carol Giltner (Director) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Granted 20,500 shares
@ $0
Granted 31,500 options to buy
@ $7.35, valued at
$231.5k
|
|
| 06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|